A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat

Completed

Conditions studied: Multiple Myeloma

In brief

This study aims to describe current treatment patterns in the real-world setting among patients with multiple myeloma who are initiating treatment with (or changing treatment to) panobinostat and explore the associations with baseline patient characteristics, healthcare resource utilization, and clinical outcomes.

Key facts

Study ID
NCT04150289
Run by
pharmaand GmbH
People needed
248
Starts
2019-11-04
Expected to finish
2022-03-30
Last updated by the study team
2023-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.